3-N-Me-Phe-morphiceptin,
morphiceptin, N-Me-Phe(3)-,
morphiceptin, N-Me-Phe(3)-, all L-isomer,
morphiceptin, N-methylphenylalanine(3)-,
PL 017,
PL 17,
PL-017,
PL-17,
PL17,
Tyr-Pro-N-MePhe-Pro-NH2,
tyrosyl-prolyl-N-methylphenlalanyl-prolinamide,
3-N-Me-Phe-morphiceptin,
PL 017,
83397-56-2,
PL017,
PL-017,
CHEMBL283287,
Tyr-Pro-NMePhe-D-Pro-NH2,
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2R)-2-carbamoylpyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-N-methylpyrrolidine-2-carboxamide,
PL 17,
Tyr-pro-N-mephe-pro-NH2,
PLO17,
Morphiceptin, N-Me-phe(3)-,
L-Tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-D-prolinamide,
Morphiceptin, N-methylphenylalanine(3)-,
AC1L3GYN,
Tyrosyl-prolyl-N-methylphenlalanyl-prolinamide,
pl-017 TFA,
Tyr-Pro-MePhe-D-Pro-NH2,
GTPL1671,
Tyr-Pro-NMe-Phe-D-Pro-NH2,
H-Tyr-Pro-N-Me-Phe-D-Pro-NH2,
BDBM50140906,
PDSP2_001552,
ZINC14953444,
(N-Me-phe3,d-pro4)-beta-casomorphin(1-4)amide(bovine),
D-Prolinamide, L-tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-,
(S)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)-N-((S)-1-((R)-2-carbamoylpyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-N-methylpyrrolidine-2-carboxamide,
1-[2-[1-[2-amino-3-(4-hydroxyphenyl)-(2S)-propanoyl]-(5S)-dihydro-1H-5-pyrrolyl(methyl)carboxamido]-3-phenyl-(2S)-propanoyl]-(5R)-dihydro-1H-5-pyrrolecarboxamide,
D0S6BX,
C29H37N5O5,
AR-1J3492,
CID115335,
C29-H37-N5-O5,
B5249,
88753-48-4,